Bioceres Crop Solutions (BIOX) Stock Forecast, Price Target & Predictions
BIOX Stock Forecast
Bioceres Crop Solutions stock forecast is as follows: an average price target of $13.90 (represents a 62.38% upside from BIOX’s last price of $8.56) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
BIOX Price Target
The average price target for Bioceres Crop Solutions (BIOX) is $13.90 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $16.00 to $12.50. This represents a potential 62.38% upside from BIOX's last price of $8.56.
BIOX Analyst Ratings
According to 3 Wall Street analysts, Bioceres Crop Solutions's rating consensus is 'Buy'. The analyst rating breakdown for BIOX stock is 0 'Strong Buy' (0.00%), 3 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Bioceres Crop Solutions Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 11, 2024 | Ben Klieve | Loop Capital Markets | $13.00 | $8.31 | 56.36% | 51.87% |
| Sep 11, 2024 | Ben Klieve | Lake Street | $13.00 | $8.65 | 50.29% | 51.87% |
| Sep 11, 2024 | Austin Moeller | Canaccord Genuity | $12.50 | $8.36 | 49.61% | 46.03% |
| Sep 10, 2024 | Kristen Owen | Oppenheimer | $16.00 | $8.65 | 84.97% | 86.92% |
| Jul 02, 2024 | Scott Fortune | Roth Capital | $15.00 | $11.13 | 34.77% | 75.23% |
The latest Bioceres Crop Solutions stock forecast, released on Sep 11, 2024 by Ben Klieve from Loop Capital Markets, set a price target of $13.00, which represents a 56.36% increase from the stock price at the time of the forecast ($8.31), and a 51.87% increase from BIOX last price ($8.56).
Bioceres Crop Solutions Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 4 | 5 | 5 |
| Avg Price Target | $13.63 | $13.90 | $13.90 |
| Last Closing Price | $8.56 | $8.56 | $8.56 |
| Upside/Downside | 59.23% | 62.38% | 62.38% |
In the current month, the average price target of Bioceres Crop Solutions stock is $13.63, according to 4 Wall Street analysts offering twelve months forecast. The average price target represents a 59.23% increase as opposed to Bioceres Crop Solutions's last price of $8.56. This month's average price target is down -1.94% compared to last quarter, and down -1.94% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 11, 2024 | Lake Street | Buy | Buy | Hold |
| Sep 11, 2024 | Canaccord Genuity | Buy | Buy | Hold |
| Sep 10, 2024 | Oppenheimer | Outperform | Outperform | Hold |
| Sep 30, 2022 | Canaccord Genuity | - | Buy | Initialise |
Bioceres Crop Solutions's last stock rating was published by Lake Street on Sep 11, 2024. The company gave BIOX a "Buy" rating, the same as its previous rate.
Bioceres Crop Solutions Financial Forecast
Bioceres Crop Solutions Revenue Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $93.61M | $94.55M | $126.84M | $105.75M | $68.23M | $92.31M | $68.23M | $81.05M | $42.11M | $48.00M | $35.54M | $48.13M | $36.23M | $62.27M |
| Avg Forecast | $150.00M | $105.00M | $165.00M | $130.00M | $139.85M | $88.76M | $152.45M | $119.25M | $134.22M | $98.50M | $116.99M | $123.82M | $105.04M | $88.41M | $91.97M | $81.99M | $94.89M | $44.62M | $69.97M | $52.57M | $53.93M | $26.52M | $68.80M | $40.00M | $49.82M | $20.00M | $70.00M |
| High Forecast | $162.36M | $113.65M | $178.59M | $140.71M | $151.37M | $96.07M | $165.01M | $123.22M | $145.27M | $106.62M | $132.81M | $148.75M | $113.70M | $95.70M | $99.55M | $88.74M | $94.89M | $46.23M | $72.50M | $54.46M | $55.87M | $27.48M | $71.28M | $41.44M | $51.61M | $20.72M | $72.53M |
| Low Forecast | $145.94M | $102.16M | $160.53M | $126.48M | $136.07M | $86.35M | $148.32M | $113.71M | $130.58M | $95.83M | $101.62M | $102.42M | $102.20M | $86.02M | $89.48M | $79.77M | $94.89M | $43.52M | $68.25M | $51.27M | $52.60M | $25.87M | $67.11M | $39.02M | $48.59M | $19.51M | $68.28M |
| # Analysts | 2 | 3 | 2 | 1 | 1 | 2 | 3 | 4 | 2 | 1 | 3 | 5 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.06% | 1.03% | 1.55% | 1.11% | 1.53% | 1.32% | 1.30% | 1.50% | 1.59% | 0.70% | 0.89% | 0.97% | 1.81% | 0.89% |
Bioceres Crop Solutions's average Quarter revenue forecast for Jun 23 based on 2 analysts is $105.04M, with a low forecast of $102.20M, and a high forecast of $113.70M. BIOX's average Quarter revenue forecast represents a 12.22% increase compared to the company's last Quarter revenue of $93.61M (Mar 23).
Bioceres Crop Solutions EBITDA Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 3 | 2 | 1 | 1 | 2 | 3 | 4 | 2 | 1 | 3 | 5 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $29.49M | $7.67M | $20.62M | $9.61M | $4.49M | $14.59M | $4.49M | $8.65M | $9.15M | $12.31M | $6.02M | $5.88M | $9.83M | $19.57M |
| Avg Forecast | $27.83M | $19.48M | $30.61M | $24.12M | $25.95M | $16.47M | $28.29M | $22.12M | $24.90M | $18.28M | $21.71M | $22.97M | $19.49M | $16.40M | $17.06M | $15.21M | $17.61M | $-1.29M | $26.18M | $11.82M | $10.01M | $6.88M | $19.52M | $7.42M | $9.24M | $1.30M | $23.71M |
| High Forecast | $30.12M | $21.09M | $33.14M | $26.11M | $28.09M | $17.82M | $30.62M | $22.86M | $26.95M | $19.78M | $24.64M | $27.60M | $21.09M | $17.76M | $18.47M | $16.47M | $17.61M | $-1.03M | $31.41M | $14.19M | $10.37M | $8.26M | $23.43M | $7.69M | $9.58M | $1.56M | $28.45M |
| Low Forecast | $27.08M | $18.95M | $29.78M | $23.47M | $25.25M | $16.02M | $27.52M | $21.10M | $24.23M | $17.78M | $18.85M | $19.00M | $18.96M | $15.96M | $16.60M | $14.80M | $17.61M | $-1.55M | $20.94M | $9.46M | $9.76M | $5.51M | $15.62M | $7.24M | $9.02M | $1.04M | $18.97M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.80% | 0.45% | 1.36% | 0.55% | -3.48% | 0.56% | 0.38% | 0.86% | 1.33% | 0.63% | 0.81% | 0.64% | 7.57% | 0.83% |
2 analysts predict BIOX's average Quarter EBITDA for Jun 23 to be $19.49M, with a high of $21.09M and a low of $18.96M. This is -33.91% lower than Bioceres Crop Solutions's previous annual EBITDA (Mar 23) of $29.49M.
Bioceres Crop Solutions Net Income Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 3 | 2 | 1 | 1 | 2 | 3 | 4 | 2 | 1 | 3 | 5 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $28.15M | $-8.43M | $3.91M | $-4.68M | $-6.98M | $5.34M | $-6.98M | $1.38M | $-6.37M | $1.80M | $-624.52K | $3.14M | $-7.98M | $11.31M |
| Avg Forecast | $15.36M | $668.00K | $18.04M | $6.68M | $10.35M | $-1.50M | $12.53M | $5.88M | $15.63M | $11.36M | $6.15M | $6.01M | $1.34M | $-1.74M | $4.68M | $3.21M | $13.28M | $-3.89M | $9.69M | $1.31M | $12.25M | $-1.49M | $1.13M | $5.11M | $13.73M | $-3.69M | $12.00M |
| High Forecast | $17.01M | $739.53K | $19.97M | $7.40M | $11.46M | $-1.45M | $13.87M | $7.35M | $17.31M | $12.57M | $8.78M | $10.02M | $1.48M | $-1.68M | $5.18M | $3.55M | $13.28M | $-3.11M | $11.63M | $1.57M | $12.83M | $-1.19M | $1.36M | $5.35M | $14.38M | $-2.95M | $14.40M |
| Low Forecast | $14.82M | $644.48K | $17.40M | $6.44M | $9.99M | $-1.66M | $12.08M | $2.94M | $15.08M | $10.96M | $1.76M | $3.01M | $1.29M | $-1.92M | $4.51M | $3.09M | $13.28M | $-4.67M | $7.76M | $1.05M | $11.86M | $-1.78M | $907.47K | $4.95M | $13.29M | $-4.43M | $9.60M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | -16.21% | -1.80% | 1.22% | -0.35% | 1.79% | 0.55% | -5.32% | 0.11% | 4.28% | 1.59% | -0.12% | 0.23% | 2.16% | 0.94% |
Bioceres Crop Solutions's average Quarter net income forecast for Jun 23 is $1.34M, with a range of $1.29M to $1.48M. BIOX's average Quarter net income forecast represents a -95.25% decrease compared to the company's last Quarter net income of $28.15M (Mar 23).
Bioceres Crop Solutions SG&A Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 3 | 2 | 1 | 1 | 2 | 3 | 4 | 2 | 1 | 3 | 5 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $23.99M | $28.41M | $24.95M | $19.03M | $18.03M | $18.81M | $18.03M | $5.71M | $8.20M | $11.22M | $10.21M | $10.47M | $8.68M | $10.50M |
| Avg Forecast | $27.92M | $19.54M | $30.71M | $24.19M | $26.03M | $16.52M | $28.37M | $22.19M | $24.98M | $18.33M | $21.77M | $23.04M | $19.55M | $16.45M | $17.12M | $15.26M | $17.66M | $8.30M | $13.02M | $18.75M | $10.04M | $12.87M | $19.63M | $7.44M | $9.27M | $10.27M | $11.13M |
| High Forecast | $30.21M | $21.15M | $33.24M | $26.19M | $28.17M | $17.88M | $30.71M | $22.93M | $27.04M | $19.84M | $24.72M | $27.68M | $21.16M | $17.81M | $18.53M | $16.52M | $17.66M | $8.60M | $13.49M | $22.50M | $10.40M | $15.44M | $23.56M | $7.71M | $9.61M | $12.32M | $13.36M |
| Low Forecast | $27.16M | $19.01M | $29.88M | $23.54M | $25.32M | $16.07M | $27.60M | $21.16M | $24.30M | $17.83M | $18.91M | $19.06M | $19.02M | $16.01M | $16.65M | $14.85M | $17.66M | $8.10M | $12.70M | $15.00M | $9.79M | $10.29M | $15.71M | $7.26M | $9.04M | $8.21M | $8.91M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.46% | 1.66% | 1.64% | 1.08% | 2.17% | 1.44% | 0.96% | 0.57% | 0.64% | 0.57% | 1.37% | 1.13% | 0.85% | 0.94% |
Bioceres Crop Solutions's average Quarter SG&A projection for Jun 23 is $19.55M, based on 2 Wall Street analysts, with a range of $19.02M to $21.16M. The forecast indicates a -18.50% fall compared to BIOX last annual SG&A of $23.99M (Mar 23).
Bioceres Crop Solutions EPS Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 3 | 2 | 1 | 1 | 2 | 3 | 4 | 2 | 1 | 3 | 5 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.45 | $-0.14 | $0.06 | $-0.10 | $-0.17 | $0.13 | $-0.17 | $0.02 | $-0.18 | $0.02 | $-0.19 | $0.09 | $-0.22 | $0.31 |
| Avg Forecast | $0.23 | $0.01 | $0.27 | $0.10 | $0.15 | $-0.02 | $0.19 | $0.09 | $0.23 | $0.17 | $0.09 | $0.09 | $0.02 | $-0.03 | $0.07 | $0.05 | $0.20 | $-0.08 | $0.18 | $0.09 | $0.19 | $-0.04 | $0.28 | $0.08 | $0.21 | $-0.12 | $0.33 |
| High Forecast | $0.25 | $0.01 | $0.30 | $0.11 | $0.17 | $-0.02 | $0.21 | $0.11 | $0.26 | $0.19 | $0.13 | $0.15 | $0.02 | $-0.03 | $0.08 | $0.05 | $0.20 | $-0.08 | $0.19 | $0.09 | $0.20 | $-0.04 | $0.30 | $0.08 | $0.23 | $-0.11 | $0.35 |
| Low Forecast | $0.22 | $0.01 | $0.26 | $0.10 | $0.15 | $-0.02 | $0.18 | $0.04 | $0.23 | $0.16 | $0.03 | $0.04 | $0.02 | $-0.03 | $0.07 | $0.05 | $0.20 | $-0.08 | $0.18 | $0.09 | $0.19 | $-0.04 | $0.28 | $0.08 | $0.21 | $-0.12 | $0.32 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | -17.31% | -2.00% | 1.35% | -0.50% | 2.17% | 0.71% | -1.93% | 0.11% | 4.44% | 0.06% | -2.38% | 0.40% | 1.91% | 0.94% |
According to 2 Wall Street analysts, Bioceres Crop Solutions's projected average Quarter EPS for Jun 23 is $0.02, with a low estimate of $0.02 and a high estimate of $0.02. This represents a -95.56% decrease compared to BIOX previous annual EPS of $0.45 (Mar 23).
Bioceres Crop Solutions Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| AVD | American Vanguard | $6.13 | $20.00 | 226.26% | Buy |
| ICL | ICL Group | $4.19 | $7.07 | 68.74% | Hold |
| BIOX | Bioceres Crop Solutions | $8.56 | $13.90 | 62.38% | Buy |
| LVRO | Lavoro | $4.74 | $7.50 | 58.23% | Buy |
| MOS | Mosaic Company | $26.39 | $40.14 | 52.10% | Buy |
| FMC | FMC | $63.51 | $94.27 | 48.43% | Buy |
| CF | CF Industries | $79.15 | $105.35 | 33.10% | Buy |
| IPI | Intrepid Potash | $23.93 | $31.50 | 31.63% | Hold |
| CTVA | Corteva | $56.63 | $65.79 | 16.18% | Buy |
BIOX Forecast FAQ
Is Bioceres Crop Solutions a good buy?
Yes, according to 3 Wall Street analysts, Bioceres Crop Solutions (BIOX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 100.00% of BIOX's total ratings.
What is BIOX's price target?
Bioceres Crop Solutions (BIOX) average price target is $13.9 with a range of $12.5 to $16, implying a 62.38% from its last price of $8.56. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Bioceres Crop Solutions stock go up soon?
According to Wall Street analysts' prediction for BIOX stock, the company can go up by 62.38% (from the last price of $8.56 to the average price target of $13.9), up by 86.92% based on the highest stock price target, and up by 46.03% based on the lowest stock price target.
Can Bioceres Crop Solutions stock reach $13?
BIOX's average twelve months analyst stock price target of $13.9 supports the claim that Bioceres Crop Solutions can reach $13 in the near future.
What is Bioceres Crop Solutions's current price target trend?
4 Wall Street analysts forecast a $13.63 price target for Bioceres Crop Solutions (BIOX) this month, up 59.23% from its last price of $8.56. Compared to the last 3 and 12 months, the average price target increased by 62.38% and increased by 62.38%, respectively.
What are Bioceres Crop Solutions's analysts' financial forecasts?
Bioceres Crop Solutions's analysts financial forecasts for the fiscal year (Jun 2025) are as follows: average revenue is $500.31M (high $535.67M, low $484.45M), average EBITDA is $92.83M (high $99.39M, low $89.88M), average net income is $27.25M (high $31.23M, low $23.35M), average SG&A $93.11M (high $99.69M, low $90.16M), and average EPS is $0.408 (high $0.467, low $0.35). BIOX's analysts financial forecasts for the fiscal year (Jun 2026) are as follows: average revenue is $550M (high $595.31M, low $535.11M), average EBITDA is $102.04M (high $110.45M, low $99.28M), average net income is $40.75M (high $45.11M, low $39.31M), average SG&A $102.36M (high $110.79M, low $99.58M), and average EPS is $0.61 (high $0.675, low $0.589).
Did the BIOX's actual financial results beat the analysts' financial forecasts?
Based on Bioceres Crop Solutions's last annual report (Jun 2022), the company's revenue was $328.46M, beating the average analysts forecast of $262.06M by 25.34%. Apple's EBITDA was $49.33M, missing the average prediction of $54.32M by -9.19%. The company's net income was $-3.909M, missing the average estimation of $20.39M by -119.17%. Apple's SG&A was $58.18M, beating the average forecast of $57.74M by 0.77%. Lastly, the company's EPS was $-0.0924, missing the average prediction of $0.393 by -123.52%. In terms of the last quarterly report (Mar 2023), Bioceres Crop Solutions's revenue was $93.61M, beating the average analysts' forecast of $88.41M by 5.87%. The company's EBITDA was $29.49M, beating the average prediction of $16.4M by 79.77%. Bioceres Crop Solutions's net income was $28.15M, missing the average estimation of $-1.737M by -1720.56%. The company's SG&A was $23.99M, beating the average forecast of $16.45M by 45.79%. Lastly, the company's EPS was $0.45, missing the average prediction of $-0.026 by -1830.77%